秀強股份(300160.SZ):2021年度擬向銀行申請不超12億元綜合授信額度
格隆匯2月19日丨秀強股份(300160.SZ)公佈,公司於2021年2月19日召開的第四屆董事會第十六次會議審議通過《關於公司2021年度向銀行申請綜合授信額度的議案》,同意公司2021年度根據業務發展需要向銀行及其它金融機構申請不超過人民幣12億元的綜合授信額度。該事項尚需提交公司2020年年度股東大會審議通過。
根據公司2021年主營業務的生產經營、業務發展計劃,為滿足業務經營流動資金和業務發展投資資金的需求,公司2021年度擬向工商銀行、中國銀行、建設銀行、農業銀行、交通銀行、民生銀行及其它金融機構申請合計不超過人民幣12億元的銀行綜合授信額度,最終授信額度以金融機構實際審批的額度為準。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.